跳至主要内容
临床试验/CTRI/2023/06/053665
CTRI/2023/06/053665招募中2 期

A COMPARATIVE STUDY EVALUATING ACUTE TOXICITY AND BREASTCOSMESIS IN EARLY STAGE BREAST CANCER PATIENTS RECEIVINGMODERATE VERSUS EXTREME HYPOFRACTIONATED RADIOTHERAPY

I0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Histologically proven invasive carcinoma of the breast cT1-T2 N0-1M0 and cT3N0 AJCC stage 1 & 2 patients following complete excision of the primary tumour by breast conservation surgery. There should be adequate surgical resection of primary (ink negative) and nodal disease (negative sentinel lymph node biopsy or adequate axillary sampling or dissection (yield atleast 10 nodes).
  • 2. Written informed consent
  • 3. Age - 18 to 70 years
  • 4. Female gender
  • 5. ECOG Performance status 0 - 2
  • 6. Non-metastatic disease.

排除标准

  • 1. Any histopathology other than invasive carcinoma and DCIS.
  • 2. Synchronous or metachronous malignancy.
  • 3. Pregnant or lactating women.
  • 4. Uncontrolled concurrent illness like DM, HTN, tuberculosis.
  • 5. Evidence of distant metastasis.
  • 6. Recurrent or residual disease.
  • 7. Previous history of radiation to thoracic and neck area.
  • 8. Patients not meeting dose volume constraints.

研究者

发起方
I

相似试验